Home > Financial Ratios > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 26.2926.4014.7113.7811.74

What is the latest Core EBITDA Margin ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Core EBITDA Margin ratio of SUN PHARMACEUTICAL INDUSTRIES is 26.29 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202426.29
Mar202326.40
Mar202214.71
Mar202113.78
Mar202011.74

How is Core EBITDA Margin of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2024 26.29
-0.42
Mar2023 26.4
79.47
Mar2022 14.71
6.75
Mar2021 13.78
17.38
Mar2020 11.74 -

Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES


Compare Core EBITDA Margin ratio of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹416,386.5 Cr -2.8% 7.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹153,258.0 Cr -2.3% 0.8% 72.7% Stock Analytics
CIPLA ₹116,434.0 Cr -5.4% -1.5% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,474.0 Cr -0.8% 6.8% 25.6% Stock Analytics
MANKIND PHARMA ₹99,974.0 Cr 2.1% 3.7% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,465.9 Cr -5.5% 1.6% -5.1% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-2.8%

7.6%

8.4%

SENSEX

0.7%

4%

6.3%


You may also like the below Video Courses